A controlled trial of erenumab for episodic migraine
PJ Goadsby, U Reuter, Y Hallström… - … England Journal of …, 2017 - Mass Medical Soc
Background We tested erenumab, a fully human monoclonal antibody that inhibits the
calcitonin gene–related peptide receptor, for the prevention of episodic migraine. Methods …
calcitonin gene–related peptide receptor, for the prevention of episodic migraine. Methods …
[PDF][PDF] A Controlled Trial of Erenumab for Episodic Migraine
PJ Goadsby, U Reuter, Y Hallström, G Broessner… - N Engl J …, 2017 - researchgate.net
A Controlled Trial of Erenumab for Episodic Migraine Page 1 The new england journal of
medicine n engl j med 377;22 nejm.org November 30, 2017 2123 From the National Institute …
medicine n engl j med 377;22 nejm.org November 30, 2017 2123 From the National Institute …
[PDF][PDF] A Controlled Trial of Erenumab for Episodic Migraine
PJ Goadsby, U Reuter, Y Hallström, G Broessner… - N Engl J Med, 2017 - nvvg.nl
A Controlled Trial of Erenumab for Episodic Migraine Page 1 The new england journal of
medicine n engl j med 377;22 nejm.org November 30, 2017 2123 From the National Institute …
medicine n engl j med 377;22 nejm.org November 30, 2017 2123 From the National Institute …
[PDF][PDF] A Controlled Trial of Erenumab for Episodic Migraine
PJ Goadsby, U Reuter, Y Hallström, G Broessner… - N Engl J …, 2017 - kclpure.kcl.ac.uk
A Controlled Trial of Erenumab for Episodic Migraine Page 1 King’s Research Portal DOI:
10.1056/NEJMoa1705848 Document Version Publisher's PDF, also known as Version of record …
10.1056/NEJMoa1705848 Document Version Publisher's PDF, also known as Version of record …
[引用][C] A Controlled Trial of Erenumab for Episodic Migraine
PJ Goadsby, U Reuter, Y Hallström… - New England Journal …, 2017 - cir.nii.ac.jp
A Controlled Trial of Erenumab for Episodic Migraine | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
A Controlled Trial of Erenumab for Episodic Migraine.
PJ Goadsby, U Reuter, Y Hallström… - The New England …, 2017 - europepmc.org
BACKGROUND: We tested erenumab, a fully human monoclonal antibody that inhibits the
calcitonin gene-related peptide receptor, for the prevention of episodic migraine. METHODS …
calcitonin gene-related peptide receptor, for the prevention of episodic migraine. METHODS …
A Controlled Trial of Erenumab for Episodic Migraine
PJ Goadsby, U Reuter, Y Hallström… - The New England …, 2017 - pubmed.ncbi.nlm.nih.gov
Background We tested erenumab, a fully human monoclonal antibody that inhibits the
calcitonin gene-related peptide receptor, for the prevention of episodic migraine. Methods …
calcitonin gene-related peptide receptor, for the prevention of episodic migraine. Methods …
A Controlled Trial of Erenumab for Episodic Migraine
PJ Goadsby, U Reuter, Y Hallström… - New England Journal …, 2017 - kclpure.kcl.ac.uk
BACKGROUND We tested erenumab, a fully human monoclonal antibody that inhibits the
calcitonin gene–related peptide receptor, for the prevention of episodic migraine. METHODS …
calcitonin gene–related peptide receptor, for the prevention of episodic migraine. METHODS …